Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "safety"

1080 News Found

WHO, FAO, UNEP and WOAH launch One Health Joint Plan of Action
Policy | October 18, 2022

WHO, FAO, UNEP and WOAH launch One Health Joint Plan of Action

This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats


Apollo launches automated AI based patient monitoring system
Digitisation | October 15, 2022

Apollo launches automated AI based patient monitoring system

This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome


JB Pharma publishes its maiden sustainability report
Sustainability | October 14, 2022

JB Pharma publishes its maiden sustainability report

Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%


Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion
News | October 14, 2022

Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion

The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year


Dupixent Phase 3 data showed significant histological remission of eosinophilic esophagitis
Diagnostic Center | October 13, 2022

Dupixent Phase 3 data showed significant histological remission of eosinophilic esophagitis

68% of children on a higher dose of Dupixent achieved histological disease remission at week 16


Healthium launches Theruptor Novo for diabetic foot ulcers
Healthcare | October 11, 2022

Healthium launches Theruptor Novo for diabetic foot ulcers

Theruptor Novo is a best in class patented product which provides an optimum healing environment and addresses the concerns of chronic wound dressing


Merck announces positive top-line results from Phase 3 Stellar Trail evaluating Sotatercept for the treatment of PAH
Diagnostic Center | October 11, 2022

Merck announces positive top-line results from Phase 3 Stellar Trail evaluating Sotatercept for the treatment of PAH

Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy


AIIA signs MoU with AIST
Policy | October 09, 2022

AIIA signs MoU with AIST

The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines


Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant
Drug Approval | October 09, 2022

Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant

The company increases its efficiency and is able to face the growing demand for its services.


Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Diagnostic Center | October 09, 2022

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival